Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient

Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient

Chronic Myelogenous Leukemia (CML) is a myeloproliferative neoplasm characterized by proliferation of Philadelphia positive clonal pluripotent hematopoietic cells. Bleeding is a rare presentation of CML that can occur due to platelet dysfunction. Both pre-treatment and post-treatment platelet functi...

Full description

Bibliographic Details
Main Authors: Richa Chauhan, Sudha Sazawal, Kanwaljeet Singh, R. Ragesh R. Nair, Sunita Chhikara, Roopam Deka, Rekha Chaubey, Karthika Kundil Veetil, Prasad Dange, Manoranjan Mahapatra, Renu Saxena
Format: Article
Language:English
Published: Taylor & Francis Group 2018-02-01
Series:Platelets
Subjects:
acquired glanzmann thrombasthenia (gt)
pediatric chronic myeloid leukemia (cml)
platelet function defect
Online Access:http://dx.doi.org/10.1080/09537104.2017.1384539

Internet

http://dx.doi.org/10.1080/09537104.2017.1384539

Similar Items